Sheng-Chi Chen 陳勝吉

Sheng-Chi Chen 陳勝吉

Ming Chi University of Technology - New Taipei City / Taiwan
Engineering & Technology / Metallurgical & Materials Engineering
AD Scientific Index ID: 414276
明志科技大學
person_outline Sheng-Chi Chen 陳勝吉's MOST POPULAR ARTICLES
1-) MONARCH 3: abemaciclib as initial therapy for advanced breast cancerMP Goetz, M Toi, M Campone, J Sohn, S Paluch-Shimon, J Huober, ...Journal of Clinical Oncology 35 (32), 3638-3646, 201710762017
2-) Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trialM Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...The lancet oncology 18 (12), 1688-1700, 20175172017
3-) Neratinib plus capecitabine versus lapatinib plus capecitabine in HER2-positive metastatic breast cancer previously treated with≥ 2 HER2-directed regimens: phase III NALA trialC Saura, M Oliveira, YH Feng, MS Dai, SW Chen, SA Hurvitz, SB Kim, ...Journal of Clinical Oncology 38 (27), 3138, 20203582020
4-) Measurements of W γ and Z γ production in pp collisions at s<? format?>=<? format?> 7 TeV<? format?> with the ATLAS detector at the LHCG Aad, T Abajyan, B Abbott, J Abdallah, S Abdel Khalek, AA Abdelalim, ...Physical Review D—Particles, Fields, Gravitation, and Cosmology 87 (11), 112003, 20133542013
5-) Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trialM Procter, TM Suter, E De Azambuja, U Dafni, V Van Dooren, ...Journal of Clinical Oncology 28 (21), 3422-3428, 20103312010